C

Centrillion Technologies

Genomics DNA analysis and sequencing tools

Research Assistant/Associate - Product Science

Full-Time
No salary listed
Junior
Bachelor's, Master's
Palo Alto, CA, USA
In Person
Biology & BiotechTranslational Research & Bench Biology

About the job

Requirements
  • A bachelor's or master's degree with an emphasis in molecular biology, biochemistry, genetics, or a related field.
  • At least 2 years of relevant experience.
  • Demonstrated experience with molecular biology and biochemistry methods.
  • Proficiency with standard software, such as Microsoft Office.
  • Strong verbal and written communication skills.
  • Excellent organizational skills and careful attention to detail.
  • Demonstrated experience keeping accurate and detailed laboratory records.
Responsibilities
  • Carry out experiments using molecular biology and nucleic acid-based protocols, including RNA or DNA extraction, amplification, labeling, purification, quantification, PCR, qPCR, RT-PCR, array hybridization, and next-generation sequencing.
  • Produce, analyze, document, and report results, achieving reproducible, high-quality data in a timely manner.
  • Keep accurate and detailed laboratory records.
  • Communicate daily results and summarize progress with a supervisor through oral updates or written reports.
  • Troubleshoot, rapidly propose solutions, and/or seek help.
  • Professionally handle the pressure of aggressive deadlines while maintaining data quality.
Desired Qualifications
  • Experience in the biotechnology industry.
  • Experience with microarrays and next-generation sequencing.

About the company

C

Centrillion Technologies

View

Centrillion Technologies develops tools for genomic studies, including sequencing, bioinformatics, and a new generation of DNA chips designed for high-density, high-quality probes that work with sequencing. Its products include ATOM, a high-throughput detection system, and VirusHunter MVP, a pathogen-detection assay, along with sequencing and droplet digital PCR services for researchers and drug discovery groups. It differentiates itself by offering integrated genomics hardware, assays, and services with DNA chips optimized for large-scale analysis that complement sequencing workflows. Its goal is to enable broad, scalable genomic studies to accelerate drug discovery, personalized medicine, and molecular diagnostics.

Company Size

51-200

Company Stage

Series B

Total Funding

$24.3M

Headquarters

Palo Alto, California

Founded

2009

Get referred to Centrillion Technologies

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • September 2026 site updates show active product marketing and service availability.
  • Centrillion’s August 2026 AI messaging targets genome, cell, and tissue data buyers.
  • The platform keeps multiple revenue paths: research chips, diagnostics, and sequencing services.

What critics are saying

  • VirusHunter MVP remains only through Molecular Vision Laboratories as of August 2026.
  • Centrillion shows no fresh 2025-2026 financing, suggesting constrained commercial scale.
  • Illumina, Thermo Fisher, and Oxford Nanopore can crush adoption if chip volumes lag.

What makes Centrillion Technologies unique

  • Centrillion’s September 2026 chips combine 50,000-2 million variants with sequencing workflows.
  • VirusHunter pairs pathogen detection and whole-genome sequencing on ATOM and QuadCore chips.
  • The company still owns a rare integrated stack: chips, assays, and clinical-lab services.

Help us improve and share your feedback! Did you find this helpful?

Growth & Insights

6 month growth

0%

1 year growth

0%

2 year growth

4%